Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
Condition(s):X-Linked Adrenoleukodystrophy; AdrenomyeloneuropathyLast Updated:February 14, 2014Withdrawn
Hide Studies Not Open or Pending
Condition(s):X-Linked Adrenoleukodystrophy; AdrenomyeloneuropathyLast Updated:February 14, 2014Withdrawn
Condition(s):X-linked AdrenoleukodystrophyLast Updated:August 29, 2018Completed
Condition(s):X-linked AdrenoleukodystrophyLast Updated:January 23, 2018No longer available
Condition(s):AdrenomyeloneuropathyLast Updated:April 4, 2023Not yet recruiting
Condition(s):Adrenomyeloneuropathy; X-linked AdrenoleukodystrophyLast Updated:September 10, 2019Completed
Condition(s):ALD (Adrenoleukodystrophy)Last Updated:April 5, 2023Not yet recruiting
Condition(s):AdrenoleukodystrophyLast Updated:July 12, 2018Completed
Condition(s):Cerebral AdrenoleukodystrophyLast Updated:July 18, 2023Active, not recruiting
Condition(s):Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)Last Updated:May 22, 2023Recruiting
Condition(s):Cerebral Adrenoleukodystrophy (CALD)Last Updated:January 25, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.